Entod Pharmaceuticals
Manufacturing · United Kingdom · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
15 Tottenham Lane, Tottenham Lane Office...Phone Number
+91 2226423608Website
www.entodpharma.comRevenue
$29.6 MillionIndustry
About Entod Pharmaceuticals
ENTOD Pharmaceuticals is a leading international pharmaceutical company specializing in ophthalmic, ENT, and dermatological medicines, with over four decades of expertise. They offer a diverse portfolio of over 300 products, including eye drops, nasal sprays, and skincare solutions, catering to therapeutic needs globally. The company operates state-of-the-art manufacturing and research facilities, ensuring compliance with international quality standards and exporting to over 67 countries. Their research teams focus on innovative therapies, supported by partnerships with international research entities.Explore more
SIC Code 28,283NAICS Code 32,325Show moreEntod Pharmaceuticals Org Chart
Compare Similar Companies to Entod Pharmaceuticals
Compare insights from companies similar to Entod Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$12.9M
201-500
Private
-
1994
SB
Sarah BaischAnalytical QC, Stability & Micro Associate Director, Quality Control
Entod Pharmaceuticals Tech Stack
A closer look at the technologies used by Entod Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Entod Pharmaceuticals
Sign Up For FreeTo access detailed company insights
ENTOD Pharmaceuticals is a leading international pharmaceutical company specializing in ophthalmic, ENT, and dermatological medicines, with over four decades of expertise. They offer a diverse portfolio of over 300 products, including eye drops, nasal sprays, and skincare solutions, catering to therapeutic needs globally. The company operates state... Read More